Anti-transcription intermediary factor 1-gamma autoantibody ELISA development and validation

Objectives. A quantitative anti-transcription intermediary factor 1-gamma (anti-TIF1-γ) ELISA may improve the detection of cancer-associated myositis (CAM). The aims of this study were the development and validation of a quantitative anti-TIF1-γ autoantibody ELISA in patients with myositis. Methods....

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Aggarwal, Rohit, Oddis, Chester V., Goudeau, Danielle, Fertig, Noreen, Metes, Ilinca, Stephens, Chad, Qi, Zengbiao, Koontz, Diane, Levesque, Marc C.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2014
Pynciau:
Basic Science
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3930887/
https://ncbi.nlm.nih.gov/pubmed/24255164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/ket383
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg